METHODS OF TREATING THE DEREGULATED NUCLEAR FACTOR OF SHORT-CHAIN KAPPA ACTIVATED CELL ENHANCER IN (NF-κB) IN ORGANISM IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS
The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-κB”) in the gut of a host in need thereof and methods of treating conditions related to NF-κB dysregulation.